Literature DB >> 26085995

Standardization of choroidal thickness measurements using enhanced depth imaging optical coherence tomography.

Nattapon Boonarpha1, Yalin Zheng1, Alexandros N Stangos2, Huiqi Lu1, Ankur Raj1, Gabriela Czanner3, Simon P Harding1, Jayashree Nair-Sahni1.   

Abstract

AIM: To describe and evaluate a standardized protocol for measuring the choroidal thickness (ChT) using enhanced depth imaging optical coherence tomography (EDI OCT).
METHODS: Single 9 mm EDI OCT line scans across the fovea were used for this study. The protocol used in this study classified the EDI OCT images into four groups based on the appearance of the choroidal-scleral interface and suprachoroidal space. Two evaluation iterations of experiments were performed: first, the protocol was validated in a pilot study of 12 healthy eyes. Afterwards, the applicability of the protocol was tested in 82 eyes of patients with diabetes. Inter-observer and intra-observer agreements on image classifications were performed using Cohen's kappa coefficient (κ). Intraclass correlation coefficient (ICC) and Bland-Altman's methodology were used for the measurement of the ChT.
RESULTS: There was a moderate (κ=0.42) and perfect (κ=1) inter- and intra-observer agreements on image classifications from healthy eyes images and substantial (κ=0.66) and almost perfect (κ=0.86) agreements from diabetic eyes images. The proposed protocol showed excellent inter- and intra-observer agreements for the ChT measurements on both, healthy eyes and diabetic eyes (ICC>0.90 in all image categories). The Bland-Altman plot showed a relatively large ChT measurement agreement in the scans that contained less visible choroidal outer boundary.
CONCLUSIONS: A protocol to standardize ChT measurements in EDI OCT images has been developed; the results obtained using this protocol show that the technique is accurate and reliable for routine clinical practice and research.

Entities:  

Keywords:  choroid; choroidal thickness; diabetes; enhanced depth imaging; optical coherence tomography

Year:  2015        PMID: 26085995      PMCID: PMC4458650          DOI: 10.3980/j.issn.2222-3959.2015.03.09

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  31 in total

1.  Choroidal thickness in healthy Chinese subjects.

Authors:  Xiaoyan Ding; Jiaqing Li; Jing Zeng; Wei Ma; Ran Liu; Tao Li; Shanshan Yu; Shibo Tang
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-12-20       Impact factor: 4.799

2.  Measurement and reliability: statistical thinking considerations.

Authors:  J J Bartko
Journal:  Schizophr Bull       Date:  1991       Impact factor: 9.306

3.  Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes.

Authors:  Takamitsu Fujiwara; Yutaka Imamura; Ron Margolis; Jason S Slakter; Richard F Spaide
Journal:  Am J Ophthalmol       Date:  2009-07-09       Impact factor: 5.258

4.  Reproducibility of choroidal thickness measurements across three spectral domain optical coherence tomography systems.

Authors:  Lauren Branchini; Caio V Regatieri; Ignacio Flores-Moreno; Bernhard Baumann; James G Fujimoto; Jay S Duker
Journal:  Ophthalmology       Date:  2011-09-23       Impact factor: 12.079

5.  Optical coherence tomography in photodynamic therapy for subfoveal choroidal neovascularisation secondary to age related macular degeneration: a cross sectional study.

Authors:  J Sahni; P Stanga; D Wong; S Harding
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

6.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

7.  Enhanced depth imaging optical coherence tomography of the sclera in dome-shaped macula.

Authors:  Yutaka Imamura; Tomohiro Iida; Ichiro Maruko; Sandrine A Zweifel; Richard F Spaide
Journal:  Am J Ophthalmol       Date:  2010-12-03       Impact factor: 5.258

8.  Lack of association between glaucoma and macular choroidal thickness measured with enhanced depth-imaging optical coherence tomography.

Authors:  Jean-Claude Mwanza; Jessica T Hochberg; Michael R Banitt; William J Feuer; Donald L Budenz
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-18       Impact factor: 4.799

9.  Choroidal evaluation using enhanced depth imaging spectral-domain optical coherence tomography in Vogt-Koyanagi-Harada disease.

Authors:  Angie H C Fong; Kenneth K W Li; David Wong
Journal:  Retina       Date:  2011-03       Impact factor: 4.256

10.  Repeatability and reproducibility of choroidal vessel layer measurements in diabetic retinopathy using enhanced depth optical coherence tomography.

Authors:  Dawn A Sim; Pearse A Keane; Hemal Mehta; Simon Fung; Javier Zarranz-Ventura; Marcus Fruttiger; Praveen J Patel; Catherine A Egan; Adnan Tufail
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-23       Impact factor: 4.799

View more
  4 in total

1.  Repeatability of choroidal thickness measurements with Spectralis OCT images.

Authors:  Jason K Lau; Sin Wan Cheung; Michael J Collins; Pauline Cho
Journal:  BMJ Open Ophthalmol       Date:  2019-04-23

2.  Can ocular changes be detected early in children and adolescents with type 1 diabetes mellitus without retinopathy by using optical biometry and optical coherence tomography?

Authors:  Hakan Öztürk; Bediz Özen; Hayrullah Manyas; Gönül Çatlı; Bumin Dündar
Journal:  Int Ophthalmol       Date:  2020-06-01       Impact factor: 2.031

3.  Visual Recovery after Macular Hole Surgery and Related Prognostic Factors.

Authors:  Soo Han Kim; Hong Kyu Kim; Jong Yun Yang; Sung Chul Lee; Sung Soo Kim
Journal:  Korean J Ophthalmol       Date:  2018-03-13

4.  Assessment of Inner Retinal Layers and Choroidal Thickness in Type 1 Diabetes Mellitus: A Cross-Sectional Study.

Authors:  Marc Carbonell; Núria Alonso; Esmeralda Castelblanco; Jordi Real; Anna Ramírez-Morros; Rafael Simó; Cristina Hernández; Carme Jurjo; Alícia Traveset; Xavier Valldeperas; Dídac Mauricio
Journal:  J Clin Med       Date:  2019-09-08       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.